David Cox Dies

David Cox, a senior vice president at Pfizer, has died, reports Matthew Herper at Forbes. Cox was 66. As Herper notes, Cox was part of the effort to sequence the human genome, then was the chief scientific officer of Perlegen before moving onto Pfizer where he oversaw genetic research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Sewer Sequences

The One to Beat

23andMe's Data Deal

Can It Be Done?

Fido's Prescription

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.